The Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals.
American Society of Hematology. (2022).
FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals.
Retrieved from https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2022/fda-authorizes-second-booster-dose-for-older-and-immunocompromised-individuals.
American Society of Hematology.
"FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals." Hematology.org.
https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2022/fda-authorizes-second-booster-dose-for-older-and-immunocompromised-individuals
(label-accessed April 26, 2024).
"American Society of Hematology."
FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals, 26 Apr. 2024 ,
https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2022/fda-authorizes-second-booster-dose-for-older-and-immunocompromised-individuals.
